Phillip Andrew Dennis, Chief Medical Officer at NovaBridge Biosciences, sold NBP on Sep 18, 2026
Data as of Oct 27
▼ SELL$5.8K8,209 shares at $0.71Phillip Andrew Dennis Chief Medical OfficerNBP NovaBridge Biosciences
- Traded
- Sep 18, 2026
- Disclosed
- Sep 21, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
NBP since disclosure
−22.0%
after the sale
Similar stocks (SPY) since disclosure
−0.5%
S&P 500 (SPY)
Change in closing price from Sep 21, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.